

Prof Lars Erik Kristensen
Professor Lars Erik Kristensen is Head of Research at the Parker Institute in Copenhagen, Denmark, and holds an honorary doctoral position at Lund University, Sweden, and a professorship at Copenhagen University, Denmark. He received his medical degree from Copenhagen University and a PhD in Clinical Medicine from Lund University. He later specialised in internal medicine and rheumatology. Professor Kristensen also completed a postdoc at Karolinska University, Sweden.
Professor Kristensen’s research interests are degenerative and inflammatory arthritis, with a focus on patient value, lifestyle factors, treatment response and predictors thereof in randomised controlled trials and observational settings. He also managed his own research group (South Swedish Arthritis Treatment Group [SSATG]) in Lund from 2011 to 2013. Professor Kristensen is also a board member and head of research at the Danish Society of Rheumatology. He has given >250 lectures at national and international congresses and meetings.
Explore which treatment targets may be more appropriate for making treatment decisions in axSpA.
PsA and axSpA have overlapping disease manifestations which are driven by inflammation.1 Explore several extracellular cytokines that are implicated in these...
Watch Prof Frank Behrens discuss the importance of treating skin symptoms in addition to musculoskeletal symptoms for patients with SpA.
Achieving ACR50 is associated with improvements in quality of life for patients with PsA.1 Dive into the data supporting higher treatment targets in clinical...
Watch Prof Lars Erik Kristensen and Prof Frank Behrens discuss how MDA is a realistic treatment target in clinical practice and the barriers to achieving it for...
Treatment for PsA should target a broad range of musculoskeletal and extra-articular manifestations.1 Listen to Assoc. Prof Philipp Sewerin explain how MDA can...